Corus Pharma
Corus Pharma Inc., a Seatle-based biotech and specialty drug company focused on respiratory and infectious diseases.
Business Model:
Revenue: $0
Employees: 501-1,000
Rankings
Industries / Tags:
Detailed Corus Pharma Information
Corus Pharma was acquired by
Gilead Sciences.
The acquisition happend on 2006-10-22.
Details of the transaction were not public
Acquirer
Geographic Data
Address:
City: Seattle
State: Washington
Zip:
Country: United States
Financial Info
Stage:
series unknown
Raised Last:
$25M
Raised Total:$150M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Corus Pharma is a biotech and specialty drug company that focuses on respiratory and infectious diseases. In other words, it is a development stage biopharmaceutical company that focuses on the development and commercialization of novel applications and formulations of known therapeutics to treat severe respiratory diseases. The products of the company are Corus 1020 and 1030. Corus 1020 is designed to treat respiratory infections in cystic fibrosis patients, using an inhalable form of an antibiotic called aztreonam. Corus 1030 is inhaled lidocaine for the treatment of patients suffering from the severe persistent forms of asthma. Corus Pharma is a U.S.-based company that was founded in 2001 and the company was acquired by Gilead Sciences on October 22, 2006.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
